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a b s t r a c t
MicroRNAs (miRNAs) are small noncoding RNAs that regulate basic biological processes by posttran-
scriptional suppression of their target genes. Altered miRNA expression may lead to widespread gene
expression changes and has been implicated in pathophysiological processes such as cancer and inﬂam-
mation. In this review, we summarize the present knowledge about the role of miRNAs in inﬂammation
and in the response to environmental agents and pollutants, such as cigarette smoke, ethanol, carcino-eywords:
iRNA
nﬂammatory diseases
mmunity
nvironmental pollution
genic chemicals such as benzo(a)pyrene (BaP) and dioxin, and UV radiation.
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. Introduction
MicroRNAs (miRNAs) are small, approximately 19–23nt long,
ingle-stranded non-coding RNAs that are encoded in the genome
nd regulate the expression of protein-coding genes [1]. MiRNAs
ave been implicated in the regulation of a wide variety of bio-
ogical processes including development, cell differentiation and
roliferation, as well as immunity and inﬂammation [2]. In this
eview, we will provide an overview of the involvement of miRNAs
n inﬂammation and we will summarize the current knowledge on
he association of miRNAs with exposure to environmental pollu-
ants.
The ﬁrst miRNA, named lin-4, was discovered in Caenorhabditis
legans in 1997 [3,4]. This gene regulated developmental transi-
ions [4] and did not code for a protein but a long, non-protein
oding transcript, which was processed into small functional RNAs.
hese small RNA molecules repressed the production of the lin-
4 protein at the posttranscriptional level. Although at the time of
his discovery, lin-4 was thought to be an exception, a few years
ater, hundreds of similar small functional RNAs were discovered
n every multicellular organism analyzed, including plants, nema-
odes, arthropods and vertebrates [5]. In 2001, the term “miRNA”
ogether with a systematic nomenclature was ofﬁcially introduced
o designate newly discovered small RNA-coding genes whose
unction is the regulation of protein-coding genes [5–7]. Today, we
nderstand that miRNAs represent a novel layer in the regulation
f the ﬂow of genetic information and cellular functions. Similar to
ranscription factors, miRNAs are a critical component of the com-
lex system, which deﬁnes the rate by which genetic information
s expressed.
MiRNAs are encoded in the genomic DNA, and most of them
re transcribed by RNA polymerase II. The produced long primary
ranscript (from few hundred to few thousands bases; pri-miRNA)
s sequentially processed ﬁrst in the cell nucleus and then in the
ytoplasm to generate the mature, biologically active miRNA [8].
irst, an RNase III enzyme, Drosha cleaves the primary transcript in
he nucleus and generates an approx. 70nt long RNA hairpin (pre-
iRNA), which is then exported into the cytoplasm by Exportin 5.
nother RNase III enzyme, Dicer, cleaves the miRNA hairpin into an
pproximately 22-mer RNA duplex. Most often only one of the two
trands becomes the mature miRNA via separating from the other
trand and incorporating into the RNA Induced Silencing Complex
RISC). This RNA-protein complex can bind to the 3′ untranslated
egion (3′UTR) of protein coding mRNAs present in the cytoplasm
f the host cell and inhibit protein production via translational sup-
ression, RNA-cleavage, or a combination of these twomechanisms
5,8]. Of note, not all nucleotides of the ∼22nt long miRNA par-
icipate in the base-paring, but 6–8nt of the 5′ end of the miRNA
called the “seed”) has a predominant role in deﬁning the interac-
ion, while the remaining nucleotides have complementary roles
n this process [9].
A particularly interesting feature of miRNA-mediated gene reg-
lation is that one miRNA can have dozens if not hundreds of
unctional targets within a cell type [6,7], each carrying the com-
lementary sequences to the miRNA seeds in their 3′UTRs. To
urther add to the complexity of miRNA-mediated gene regula-
ion, not only can one miRNA regulate hundreds of targets, but
lso each target can be regulated by multiple miRNAs simul-
aneously. This is made possible by the fact that mRNAs with
ong 3′UTRs may contain dozens or more miRNA binding sites
10]. The effect of multiple miRNAs targeting the same mRNAPlease cite this article in press as: E. Sonkoly, A. Pivarcsi,MicroRNAs in inﬂam
Mutat. Res.: Fundam. Mol. Mech. Mutagen. (2011), doi:10.1016/j.mrfmmm
ay be additive or synergistic, resulting in a higher degree of
nhibition. In some aspects, the action of miRNAs can be com-
ared to the action of transcription factors in terms of pleiotropy,
lthough they act on different levels in the ﬂow of genetic informa-
ion. PRESS
esearch xxx (2011) xxx–xxx
Although bioinformatic predictions suggest that most of the
genes are subject to miRNA-mediated regulation, there seem to
be exemptions [10]. Genes which need to be transcribed constitu-
tively at a high level, such as house-keeping genes, or antimicrobial
peptides necessary in large amounts after induction, tend to have
very short 3′UTRs presumably to avoid interference with miRNAs.
Interestingly, cells can change the set of 3′UTRs utilized by mRNAs
when they undergo activation. A large part of the transcripts in
activated T cell switches to alternative set of 3′UTRs, most of which
are shorter than the canonical ones, presumably to avoid miRNA-
mediated regulation during T cell activation [11]. Recently it has
been found that some pseudogenes (i.e. dysfunctional relatives of
known genes that have lost their protein-coding ability and are
generally thought to have no biological function) are expressed in
tumor cells and can regulate the expression of their coding “pair”
by luring away miRNAs targeting the corresponding region of the
coding mRNA [12].
Since their discovery, miRNAs have been implicated in
virtually every biological process investigated. MiRNAs regu-
late development, organogenesis, basic biochemical processes,
signal transduction, cell proliferation, apoptosis and migra-
tion/invasion. Shortly after their discovery in human, deregulated
miRNA expression was found in disease states such as can-
cer [13–18], developmental abnormalities [19], muscular [20,21]
and cardiovascular disorders [22,23], schizophrenia [24] and
in immune-mediated and inﬂammatory diseases [25–27]. More
recently,miRNAshave also been implicated in the cellular response
to environmental agents and associated diseases.
Since the 1970s there has been increasing global concern
over the public health impacts attributed to environmental pollu-
tion. The World Health Organization (WHO) estimates that about
a quarter of the diseases facing mankind today occurs due to
prolonged exposure to environmental pollution. Several environ-
mental chemicals including benzo(a)pyrene, dioxin, furan and
conazoles are known to be carcinogenic, and exposure to ultra-
violet (UV) radiation is a major risk for skin cancer. Exposure to
airborne particulate matter (for example from diesel exhaust) has
been associated with cardiovascular and respiratory diseases [28].
The adverse health effects of cigarette smoke are well-known and
include smoking-related malignancies, chronic obstructive lung
disease and cardiovascular diseases [29,30]. The mechanism by
which these environmental exposures lead to impaired health and
diseases is only partially known. While the capability of environ-
mental exposures to produce DNA mutations has been a landmark
for risk assessment and prevention, recent evidence suggests that
some environmental factors cause epigenetic changes which may
increase the risk of disease [31]. Most recently, environmen-
tal factors mentioned above have been linked to altered miRNA
expression suggesting that miRNAs may be involved in the adverse
health effects of these exposures.
2. MiRNAs in inﬂammation
The involvement of miRNAs in the regulation of immune sys-
tem development was established already a few years after the
discovery of miRNAs [32]. Not only can miRNAs regulate linage
commitment during hematopoiesis, but they can also regulate
the innate and adaptive immune responses upon encounter with
pathogens or antigens, respectively [33–35]. In parallel with the
investigation of their roles in the basic immune function, the atten-mation and response to injuries induced by environmental pollution,
.2011.02.002
tion of researchers turned to their potential roles in diseases in
which the immune system malfunctions: chronic inﬂammatory
conditions of various organs [2,26,36].
The ﬁrst studies focused on the identiﬁcation of deregu-
lated miRNAs in various inﬂammatory diseases in comparison to
 INGM
tion R
c
ﬁ
l
m
o
t
m
i
l
[
c
t
b
m
T
b
2
r
b

s
s
a
o
w
e
i
a
m
f
c
r
i
1
T
c
m
t
2
s
t
b
[
a
e
a
s
m
i
1
c
i
t
s
m
I
t
o
iARTICLEModelUT-11022; No.of Pages8
E. Sonkoly, A. Pivarcsi / Muta
orresponding healthy organs/tissues. A miRNA expression pro-
ling study revealed deregulated miRNA expression in the skin
esions of patients with psoriasis and atopic dermatitis, two com-
on chronic inﬂammatory diseases with different immunopathol-
gy [25]. This study identiﬁed miRNAs with similar regulation in
hese two diseases, suggesting a general role for these in inﬂam-
atoryprocesses, but alsodisease-speciﬁcmiRNAs. Further studies
dentiﬁed deregulated miRNAs rheumatoid arthritis, [37], systemic
upus erythematosus [38], multiple sclerosis [39], type I diabetes
40] and ulcerative colitis [41]. In accordance with our view that
hronic inﬂammatory diseases have several shared components in
heir pathophysiology irrespective of the affected organ, a num-
er of commonly dysregulated miRNA have been identiﬁed in
any diseases, while other microRNAs are more disease-speciﬁc.
he role of a few selected miRNAs in inﬂammation is discussed
elow.
.1. MiR-146
MiR-146 was among the ﬁrst miRNAs to be implicated in the
egulation of immune functions [33]. This miRNA is induced by
acterial superantigens and pro-inﬂammatory cytokines in an NF-
B dependant manner and targets two members of the TLR/IL-1
ignal transduction pathway [25,33]. Increased miR-146 expres-
ion was found in psoriasis skin lesions [25], in synovial tissue
nd leukocytes in rheumatoid arthritis patients [37,42,43], and in
steoarthritis [44], in accordancewith the fact that theNF-B path-
ay is activated in a number of inﬂammatory disorders. Recent
vidence suggests that miR-146 can suppress the production of
nﬂammatory cytokines/chemokines [45] suggesting that it acts as
negative regulator of inﬂammatory cytokine production. Thus,
iR-146 may represent the effector arm of a negative regulatory
eedback-loop in inﬂammation: it is induced by pro-inﬂammatory
ytokines/bacterial products and in turn it suppresses the cytokine
esponse presumably to prevent tissue damage due to excess of
nﬂammation. Interestingly, in systemic lupuserythematosus,miR-
46 is down-regulated and correlates with disease severity [46].
he seemingly opposite roles for miR-146 in inﬂammation indi-
ate the complexity of miRNA functions and the fact that miRNAs
ay have very different functions depending on cell type and con-
ext.
.2. MiR-21
MiR-21 is an oncogenic miRNA, which is often overexpressed in
olid tumors [47]. In T cells, miR-21 is induced upon T cell recep-
or (TCR) engagement and is supposed to control T cell activation
y targeting RASGRP1, a key regulator in TCR signal transduction
2,48]. Moreover, miR-21 is induced by LPS in mouse lung [34]
nd it has been shown to be induced in several inﬂammatory dis-
ases including psoriasis, atopic eczema/dermatitis [25], a murine
sthma model [49] and ulcerative colitis [50]. Results from the
tudy by Lu et al. identifying miR-21 in an IL-13-induced asthma
odel suggest a mechanism by which this miRNA may be involved
n the regulation of allergic airway inﬂammation. They identify IL-
2p35, a subunit of IL-12, as a target for miR-21. IL-12 is a key
ytokine in adaptive immune responses involving Th1 cell polar-
zation. These results imply thatmiR-21 is involved in inﬂammation
hrough, at least in part, bymodulating cytokine responses and TCR
ignal transduction. Interestingly, recent evidence suggests thatPlease cite this article in press as: E. Sonkoly, A. Pivarcsi,MicroRNAs in inﬂam
Mutat. Res.: Fundam. Mol. Mech. Mutagen. (2011), doi:10.1016/j.mrfmmm
iR-21may be one of themiRNAs that link inﬂammation to cancer.
liopoulos et al. showed that STAT-3 can induce miR-21 that in turn
argets PTEN and CYLD tumor suppressors; hence, miR-21 is part
f the positive feedback loop that underlies the epigenetic switch
nitiated that links inﬂammation to carcinogenesis [51]. PRESS
esearch xxx (2011) xxx–xxx 3
2.3. MiR-126
Exposure of sensitized individuals to house dust mite allergen
results in airway inﬂammation and worsens asthmatic condition.
In a mouse model of asthma, house dust mite allergens induced the
expression of several miRNAs, including miR-21 and miR-126 [52].
Mattes et al. showed that administration ofmiR-126 inhibitors into
asthmatic mice suppressed the asthmatic phenotype, and resulted
in diminished Th2 responses, inﬂammation, airways hyperrespon-
siveness, eosinophil recruitment, andmucus hypersecretion. These
results indicate a functional role formiR-126 in asthma pathogene-
sis and suggest that interference with miRNA expression may have
a therapeutic potential in treating asthma.
2.4. MiR-155
MiR-155 is a multifunctional miRNA that has been implicated in
both cancer and inﬂammation. Similar to miR-21, miR-155 is fre-
quently overexpressed in cancer and functions as an oncogene [53].
In addition, miR-155 is essential for normal immune homeostasis
and is involved in the regulation of innate and adaptive immunity
[38,54–56]. Along with miR-146, miR-155 is regulated by LPS in
an NF-B dependant manner. Moreover, miR-155 is induced dur-
ing T cell activation by T cell speciﬁc stimulants or superantigens
[57].
In line with its high expression in activated T cells, miR-155
has been shown to be up-regulated in several inﬂammatory dis-
eases, including rheumatoid arthritis [37], ulcerative colitis [50],
Helicobacter pylori-induced gastric inﬂammation [58] and recently
in atopic eczema/dermatitis [57].
One of the recently identiﬁed targets of miR-155 is cytotoxic
T lymphocyte antigene-4 (CTLA-4) a negative regulator of T cell
activation, induced by T cell activation signal [57]. Its primary func-
tion is to prevent excess of T cell activation and thereby tissue
damage and autoimmunity upon physiological T cell activation.
Elevated levels of miR-155 in T cells results in suppressed CTLA-
4 protein levels and thereby may interfere with a physiological
feedback mechanism, which self-limits T cell activation. In accor-
dance, ectopic overexpression ofmiR-155 in primary human T cells
resulted in increased cell proliferation [57].
While miR-155 may contribute to sustained T cell activation,
in other cell types it may suppress inﬂammation. In macrophages
and in dendritic cellsmiR-155 targets several genes in LPS signaling
(FADD, IKK, Rip1 and TAB2) suggesting that miR-155 is involved
in negative regulation of the TLR pathway [38,54,59,60]. Recently
myeloid differentiation protein 88 (MyD88), an important adapter
protein in the TLR/IL-1 pathway was identiﬁed as a target of miR-
155 [61], supporting a role for miR-155 as a negative regulator of
inﬂammation.
These results suggest that miR-155 up-regulation may have
different functional consequences in different tissues/cell types:
it seems to enhance the proliferative response in lymphocytes,
while it suppresses inﬂammatory signaling in the myeloid cells.
Interestingly, the level and duration of miR-155 expression also
has a detrimental role on whether it functions as an oncogene
or immunostimulatory molecule. The permanent upregulaton of
miR-155 during prolonged inﬂammation may be a link to cancer
[62]. Elucidation of the functional role in miR-155 in inﬂammatory
diseases will require further studies.
The list of miRNAs deregulated in inﬂammatory diseases is
growingeveryyear. Interestingly, someof thede-regulatedmiRNAsmation and response to injuries induced by environmental pollution,
.2011.02.002
(for example miR146, miR-21, miR-155) seem to be parts of nega-
tive feedback mechanisms through the suppression of their target
genes. Future investigation will be needed to validate whether
they have a causative role in these diseases and whether they can
become therapeutic targets.
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Table 1
MicroRNAs regulated by environmental pollutants.
Environmental agent MicroRNA Regulation Cell/tissue type Species Reference
Cigarette smoke let-7c Down Lung Rat [65,72]
miR-34c Down Lung Rat [65]
miR-222 Down Lung Rat [65]
let-7f Down Lung Mouse [71]
miR-218 Down Bronchial epithelial cells Human [70]
miR-128b Down Bronchial epithelial cells Human [70]
miR181d Up Bronchial epithelial cells Human [70]
miR-500 Down Bronchial epithelial cells Human [70]
BaP miR-494 Up Bronchial epithelial cells Mouse [77]
miR-320 Up Bronchial epithelial cells Mouse [77]
Anti-BPDE miR-494 Up Transformed bronchial epithelial cell line Human [75]
miR-10a Down Transformed bronchial epithelial cell line Human [74]
miR-320 Up Transformed bronchial epithelial cell line Human [74]
Diesel exhaust miR-513 Up Bronchial epithelial cells Human [86]
miR-923 Up Bronchial epithelial cells Human [86]
miR-494 Up Bronchial epithelial cells Human [86]
miR-96 Down Bronchial epithelial cells Human [86]
Participate matter miR-222 Up Leukocytes Human [88]
miR-21 Up Leukocytes Human [88]
UV-A miR-21 Up Keratinocytes Human [96]
miR-203 Up Keratinocytes Human [96]
miR-205 Up Keratinocytes Human [96]
UV-B mir-24 Up NIH3T3 ﬁbroblast cell line Mouse [93]
miR-21 Up NIH3T3 ﬁbroblast cell line Mouse [93]
IH3T3
IH3T3
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let-7a Up N
. MiRNA regulation by environmental pollutants and
oxins
Environmental toxins and contaminants induce molecular
hanges, which lead to inﬂammation and cancer. Since deregu-
ation of miRNAs has been associated with inﬂammation as well
s with cancers in which they regulate tumour growth, survival
nd metastasis [16,63,64], it is conceivable that miRNAs may be
nvolved in the pathogenic effects of exogenous stimuli. In recent
ears, the ﬁrst studies investigating miRNA response to various
nvironmental stimuli appeared; these are reviewedbelowand the
ost validated ones are summarized in Table 1.
.1. MiRNAs associated with toxin exposure in the airways
.1.1. Cigarette smoke
Cigarette smoke contains >4000 chemical toxins or intoxicants.
he most common and well-known tobacco toxins are nicotine,
arbonmonoxide, formaldehyde, hydrogen cyanide, sulfur dioxide,
itrogen oxide, ammonia, polycyclic aromatic hydrocarbons, and
henitrosamines [30]. The adverse health effects of cigarette smoke
re partially due to the direct carcinogenic and oxidative effect of
oxins but cigarette smoke has also – less well studied – effects on
he immune system.
The ﬁrst study implicating miRNAs in the effects of cigarette
moke appeared in 2009, when Izzotti et al. showed the dereg-
lation of 126 out of 484 miRNAs in the lung of rats exposed to
nvironmental cigarette smoke [65]. The majority of the altered
iRNAs were downregulated, which is consistent with previ-
us ﬁndings showing mainly upregulation of mRNA and proteinPlease cite this article in press as: E. Sonkoly, A. Pivarcsi,MicroRNAs in inﬂam
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xpression in cigarette smoke-exposed lungs (Table 1) [66]. The
ownregulated miRNAs regulate stress response, apoptosis (e.g.
iR-34), proliferation (e.g. let-7 family, miR-125b), inﬂammation
e.g. miR-30a, miR-146, miR-155), and angiogenesis (e.g. miR-123,
iR-222), biological processes that are involved in the pathologicalﬁbroblast cell line Mouse [93]
ﬁbroblast cell line Mouse [93]
effects of cigarette smoke in the lung. Since the suppression of let-
7 leads to increased cell proliferation [67], down-regulation of the
let-7miRNAs by cigarette smokemay represent an early step in the
development of lung cancer. Indeed, down-regulated let-7 expres-
sion is a commonﬁnding in solid tumors, including lungcancer [68].
Thus, let-7 may be one of the molecular links connecting cigarette
smoke exposure with lung cancer. Strikingly, cigarette smoke dys-
regulates miRNA expression not only in murine lung but also in the
liver [69].
Another recent study investigated the effect of cigarette smoke
on miRNA expression in the human lung [70] by comparing miRNA
expression in human airway epithelial cells from smokers and
never smokers. The study has identiﬁed 28 differentially expressed
miRNAs, with the majority being downregulated (Table 1)[70]. Of
note, the rodent orthologues of several miRNAs downregulated in
smokers were found to be downregulated by cigarette smoke in
mouse and/or rat lungs (e.g. miR-30, miR-99, miR-125, miR-146,
miR-223, miR-218) [65,69,71], indicating the rodent and human
lung react in a similar fashion to this exposure.
One of the top downregulated miRNAs was miR-218, which
regulated MAFG, a transcription factor whose binding sites were
overrepresented among genes regulated in smokers. MiR-218
down-regulation may thus contribute to smoking-dependent
changes in the lung.
The role of miRNAs in cigarette smoke-induced inﬂammation is
more controversial: surprisingly, several inﬂammation-associated
miRNAs (e.g. miR-146, miR-155) are downregulated, although
cigarette smoke exposure is associated with inﬂammatory pro-
cesses in the lung [65].
Interestingly, cigarette-smoke-induced miRNA changes canmation and response to injuries induced by environmental pollution,
.2011.02.002
partially be prevented by a number of chemopreventive agents,
suggesting thatmiRNAsmayserveasbiomarkers for cancer chemo-
prevention [72]. However, to date, little is known about how (i.e.
induction of changes at the cellular level, or inducing tissue remod-
elling) cigarette smoke regulates miRNA expression in the lung.
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.1.2. Benzo(a)pyrene
Benzo(a)pyrene (BaP) is a member of the polycyclic aromatic
ydrocarbon (PAH) family, which are environmental contaminants
bundantlypresent in coal tar, cigarette smoke, andeven in smoked
ood. Benzo(a)pyrene is a powerful mutagen and carcinogen, and
xposure to BaP is associated with increased risk of lung and cervix
ancer [73].
Recent studieshaveaddressed the roleofmiRNAs inBaP induced
arcinogenesis. In a human bronchial epithelial cell line trans-
ormedbyanti-BPDE, themost importantmetabolite of BaP,miRNA
roﬁling showed that 45 miRNAs were upregulated and 9 were
ownregulated [74] (Table 1). Among the downregulated miRNAs
as miR-10a, a miRNA previously associated with cancer. One of
he upregulated miRNAs was miR-494, also conﬁrmed in a recent
tudy [75] showing that upregulation of miR-494 in the trans-
ormed cells leads to the suppression of the tumor suppressor
hosphatase and tensin homolog (PTEN). Based on these results,
ne possible mechanism for BaP-induced carcinogenesis may be
pregulation of miR-494, leading to the down-regulation of the
umor suppressor PTEN. Indeed, Moreover, miR-494 is upregulated
n small-cell lung cancer [76], and at the same time PTEN is known
o be downregulated in lung cancer and correlated with survival.
Although the cells used in this study were malignantly trans-
ormed, another study showed that BaP exposure also upregulates
iR-494, and another miRNA, miR-320 [77] (Table 1). Up-
egulation of miR-494 by BaP may also be protective: its inhibition
elieved cells from BaP-induced G1 arrest in bronchial epithelial
ells, suggesting that up-regulation of these miRNAs by BaP may
ontribute to the G1 arrest allowing cells to repair the damaged
NA [77] .
However, miR-320 has not been shown to be differentially
xpressed in the bronchial epithelium of smokers [70], suggest-
ng that chronic exposure to smoke may have different effects as
ompared to acute exposure in high concentrations. The effect of
hronic smoke exposure on miR-494 is not known and will require
urther investigation. Moreover, further studies will be needed to
larify the potential role of the miRNAs in the carcinogenic effect
f BaP in vivo.
.1.3. Occupational coal dust
Coal workers’ pneumoconiosis is a lung disease produced by
he inhalation of occupational coal dust. It is characterized by the
ccumulation of inﬂammatory cells in the lung, thickening of the
lveolar walls and formation of ﬁbrotic nodules. In addition to coal
ust exposure, genetic susceptibility is supposed to have a role in
he development of the disease, since only part of the exposed
ndividuals is affected [78]. A recent study revealed that a poly-
orphism (rs2292832) in the pre-miR-149 gene is associated with
signiﬁcantly increased risk of pneumoconiosis [78]. miR-149 has
een proposed to be oncogenic in renal cell carcinoma [79]; how-
ver, its role in the lung is as yet unknown and the effect of the
dentiﬁed SNPonmiR-149 expression has not been investigated. To
larify whether and how genetic variation in miR-149 contributes
o pneumoconiosis further studies will be needed.
.2. Regulation of miRNAs in the liver by environmental toxins
The liver is a major site for toxicant metabolism, and exposure
o various toxins is associated with gene expression changes in the
iver. Recent studies have investigated miRNA expression in the
iver after exposure to toxins.Please cite this article in press as: E. Sonkoly, A. Pivarcsi,MicroRNAs in inﬂam
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.2.1. Benzo(a)pyrene and dioxin
In contrast to the extensive changes in miRNA expression
n bronchial epithelial cells exposed to BaP (see above), miRNA
xpression remained unchanged in mouse liver after oral exposure PRESS
esearch xxx (2011) xxx–xxx 5
to BaP, despite widespread changes in mRNA expression [80].
Lack of change in miRNA expression has been conﬁrmed by two
different array platforms as well as qRT-PCR and suggest that
miRNA expression the liver is not responsive to BaP in vivo. Inter-
estingly, another in vivo study showed that miRNA expression
in mouse and rat liver was also unresponsive to dioxin (TCDD,
2,3,7,8-tetrachlorodibenzo-7-dioxin) [81]. Of note, TCDD operates
via the arylhydorcarbon (AHR) receptor, which is also a receptor
for BaP. Hence it is possible that liver miRNAs are not involved
in AHR-mediated processes; alternatively that they are in general
irresponsive to toxins – despite the fact that the liver is a major
site for toxicant metabolism. Future studies including exposure to
several different types of toxin will be needed to clarify whether
the observed lack of regulation is general or speciﬁc to the studied
toxins in the concentrations used.
3.2.2. Furan
Furan is an organic compound that is commonly found in foods
that undergo heat treatment, including canned and jarred foods,
and baby food containing meat. Furan is a potent carcinogen in
rodents, although the mechanism of carcinogenicity is not well
understood. In a study analyzing mRNA and miRNA changes by
PCR array after low dose furan exposure in rats [82], 11 miRNAs
were found to be down-regulated (e.g. let-7e, miR-489, miR-296)
and 2 miRNAs up-regulated (let-7a, miR-28) in the liver. Changes
in miRNA expression were accompanied by expression changes in
genes controlling cell cycle and apoptosis. Results of this study
suggest that miRNA-mediated regulation may contribute to the
carcinogenic effects of furan; however, the potential roles of miR-
NAs in furan-induced carcinogenesis need to be explored in further
studies.
3.2.3. Conazoles
Conazoles are antifungal agents used in agriculture. Some
conazoles induce liver tumors in mice, while others are not
hepatotumorigenic. A study, aiming to determine the molecular
background of conazole tumorigenicity, analyzed miRNA expres-
sion by PCR array in mouse liver after oral exposure to tumorigenic
(triadimefon and propiconazole) or nontumorigenic (myclobu-
tanil) conazoles for 90 days [83]. Interestingly, the tumorigenic
conazoles induced many more changes in miRNA expression (63
and 28 regulated miRNAs, respectively) than the nontumori-
genic conazole (1 regulated miRNA). Moreover 19 miRNAs were
regulated in the same way by triadimefon and propiconazole,
suggesting a role for these miRNAs in the tumorigenic process.
Interestingly, these miRNAs are not among those typically iden-
tiﬁed in liver cancer. Whether the identiﬁed changes may be early
markers of carcinogenesis will need to be established in future
studies.
3.3. MiRNA response to particulate matter exposure
Exposure to particulate matter (PM) in the polluted air has been
associated with adverse health outcomes, including cardiovascu-
lar and respiratory diseases [84,85]. The largest single source of
vehicular-emitted airborne particulate matter is diesel exhaust.
Exposure to diesel exhaust particles has been linked to lung cancer
and pulmonary inﬂammation, susceptibility to respiratory infec-
tions, exacerbation of asthma and chronic obstructive pulmonary
diseases [28]. The molecular mechanisms how diesel exhaust may
trigger development of these diseases remains elusive. A recentmation and response to injuries induced by environmental pollution,
.2011.02.002
study showed exposure to diesel exhaust particles had a dra-
matic effect on miRNA expression in human bronchial epithelial
cells: the expression of 197 of 313 detectable miRNAs changed
signiﬁcantly [86]. Thus the extent of changes in miRNA expres-
sion is similar to that induced by cigarette smoke [70]. MiR-513,
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iR-494, miR-923 were among the up-regulated miRNAs, while
iR-96 decreased (Table 1). The function of the regulated miRNAs
n bronchial epithelium is unknown, however based on target pre-
iction and network analysis the authors suggest that the diesel
xhaust particle-regulated miRNAs may be involved in the reg-
lation of inﬂammatory pathways and tumorigenesis. Of note,
iR-494 was also found to be up-regulated in bronchial epithelial
ells transformed by anti-BPDE [74], suggesting that this miRNA
ay be involved in the pathogenic effect of several pollutants.
uture functional studies will be needed to understand the poten-
ial role of miRNAs in adverse health effects of diesel exhaust.
Inhalation of particulatematter causes gene expression changes
n peripheral blood of exposed individuals, in particular genes
elated to inﬂammatorypathways andoxidative stress have altered
xpression after particulate matter exposure [87]. To determine
hether PM can induce changes in miRNA expression, Bollati et al.
nalyzed the expressionofmiR-21,miR-222 andmiR-146a inblood
eukocytes of foundryworkers on the ﬁrstworkday and after 3 days
f exposure [88]. Particulatematter exposure inducedmiR-222 and
iR-21 while it had no effect on miR-146a expression (Table 1).
iR-222 and miR-21 have been associated with nitric oxide sig-
aling and response to ROS production, respectively, suggesting
hat the upregulation of these miRNAs may be due to oxidative
tress. Interestingly, miR-222 correlated positively with lead expo-
ure,while therewas a negative correlation betweenmiR-146a and
xposure to leadandcadmium, indicating a role formetals in induc-
ngmolecular changes after PMexposure. Unfortunately, this study
easured only the short-term effects of particulate exposure and
id not include a control population without any exposure to par-
iculate matter. Using such a control population to compare with
xposed individuals would help in deﬁning whether chronic expo-
ure to particulate matter affects miRNA expression and whether
ltered miRNA expression contributes to the adverse health effects
f PM.
A recent in vivo study demonstrated that particulate matter
xposure affects miRNA expression not only in peripheral blood
eukocytes, but also in the myocardium [89]. Exposure to high-
oncentration metal-rich PM led to a decrease in the expression
f 14 out of 113 miRNAs in the myocardium of exposed rats. Inter-
stingly, no miRNAs were upregulated, in keeping with the results
f Izzotti et al showing mainly downregulation of miRNAs in the
igarette-smoke exposed lung [65]. The muscle-speciﬁc miRNAs
iR-1 and miR-133 were identiﬁed among the regulated miRNAs
oth of which have essential roles in heart development and have
een associatedwith heart pathologies [90]. Several inﬂammation-
ssociated miRNAs were also regulated such as miR-125, miR-146
nd miR-150. The precise role of speciﬁc miRNAs in PM-mediated
ardiac dysfunction remains to be determined.
. The effect of UV radiation on miRNA expression
UV light is an electromagnetic radiation emitted from the sun
or artiﬁcial sources). According to wavelength, UV light can be
ivided into UV-A (315–380nm), UV-B (280–315nm), and UV-C
190–280nm) [91]. The ozone layer absorbs themost harmful com-
onent of UV light, UV-C, and most of UV-B, and it is estimated that
–10% of UV radiation on the surface of Earth is UV-B and over 90%
V-A [92]. UV radiation causes fundamental cellular and molecular
hanges, including DNA damage and affects immune functions. In
he skin, excess UV irradiation is a major risk factor for skin cancer.
n addition, UV light can cause skin inﬂammation, immunosup-Please cite this article in press as: E. Sonkoly, A. Pivarcsi,MicroRNAs in inﬂam
Mutat. Res.: Fundam. Mol. Mech. Mutagen. (2011), doi:10.1016/j.mrfmmm
ression and promotes ocular diseases. Since miRNAs have been
hown to be involved in apoptosis and DNA damage responses
s well as immune functions, the question arose whether part of
he widespread cellular changes caused by UV radiation may be
ediated by miRNAs. PRESS
esearch xxx (2011) xxx–xxx
The ﬁrst study investigating the effects of UV-B radiation on
miRNA expression in mammalian cells was published in 2009 [93].
In this study, the mouse ﬁbroblast cell line NIH3T3 was irradiated
with UV-B light and miRNA expression proﬁling was carried out.
UV-B irradiation resulted in robust changes in miRNA expression,
in particular 4h after irradiation, suggesting a role for miRNAs in
the early UV response. Among the up-regulated miRNAs was let-
7a, a miRNA known to regulate cell proliferation, miR-24, known
to be involved in cell cycle regulation and miR-21, a miRNA also
up-regulated in several cancer types and in inﬂammation. The
upregulation of miR-21 together with miR-24 has been shown to
inhibit cell growth; thus the G1 arrest observed after UV irradia-
tion may in part be mediated by concordant upregulation of these
miRNAs.
In line with these results, UV-C irradiation induced extensive
changes in miRNA expression in HeLa cells as well as in ﬁbrob-
lasts, with most pronounced changes after 4h and up-regulation
of most miRNAs [94,95]. Although some miRNAs were found to be
regulated in both studies (e.g. miR-21, miR-24), many miRNAs are
not overlapping and may reﬂect a difference between the effects of
UV-B and UV-C. Interestingly, in cancers and after exposure to car-
cinogens a general down-regulation of miRNAs is observed; this
suggests that the carcinogenic effect of UV may not be directly
mediated by miRNA regulation.
The effect of UV-A and UV-B irradiation on the expression
of 4 miRNAs in primary human keratinocytes has been recently
investigated [96]. UV-A irradiation had a more pronounced effect
compared with UV-B; while UV-A induced miR-21, miR-203 and
miR-205, UV-B slightly induced miR-203, reduced miR-205 and
had no effect on miR-21. In line with this, we observed that only
fewmiRNAswere regulated in three-dimensional epidermal equiv-
alents irradiated with UV-B light (unpublished observations). The
effect of UV-B irradiation on miRNAs seems thus to vary dependant
on either cell type or time after irradiation.
Does UV-induced miRNA regulation contribute to the cellu-
lar and molecular responses to UV irradiation? When silencing
Dicer and Ago2, essential components in the miRNA processing
pathway, cell survival after UV-C-induced damage in HeLa cells
was reduced [94,95], suggesting that miRNAs are involved in UV-
induced apoptosis and cell cycle arrest. UV irradiation triggered
the relocalization of Ago2 into stress granules, a phenomenon also
observed previously in response to other stress stimuli; however,
the potential role of this process in UV-induced cellular responses
is as yet unclear. The speciﬁc miRNAs involved in the UV-induced
stress response also remain tobe identiﬁed. It seems that the effects
of UV light on miRNA expression can only partially be general-
ized to other cell/tissue types, and the effects may differ in a tissue
composed of many different cell types such as skin.
5. Conclusions
MiRNAs are the most abundant regulators of gene expression in
our genome and they have an enormous regulatory potential. It is
now well established that these small noncoding RNA molecules
regulate essential biological processes and that their expression is
frequently deregulated in diseased tissues. It has also been shown
that modulation of miRNA activity can result in favorable ther-
apeutic response in animal models of diseases. The forthcoming
years will answer the question whether therapeutic modulation of
miRNA activity can have beneﬁcial effects for the patients suffering
in chronic inﬂammatory diseases.mation and response to injuries induced by environmental pollution,
.2011.02.002
Several studies showed that toxins and pollutants such as
cigarette smoke, chemicals, particulate matter as well as UV radia-
tion regulatemiRNAexpression. Investigationof the role ofmiRNAs
in the cellular response to environmental stimuli is still in its
infancy. However, given the important role of miRNAs in cancer
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nd inﬂammation, it is plausible that miRNAs are involved in the
roinﬂammatory and carcinogenic effects of these environmen-
al stimuli. Future studies will be needed to explore whether the
bserved changes in miRNA expression are indeed linked to a func-
ional response.
Surprisingly, intact, mature miRNAs circulate in plasma and
erum and their levels change in disease states. One may hypothe-
ize that altered miRNA levels may be detected in plasma/serum
f patients suffering from inﬂammatory diseases or individuals
xposed to toxins and pollutants thus providing a novel class of
seful biomarkers.
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